- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06401174
Patient Navigation for Colorectal Cancer Screening (SCREEN)
October 20, 2025 updated by: Medstar Health Research Institute
Bridging the Gap: Delivering Equitable Colorectal Cancer Screening
Patient navigation is an evidence-based strategy to increase screening rates among racial and ethnic minorities, but there is a gap in understanding the multi-level influences on implementation of such programs across primary care practices.
The investigators will conduct a stepped-wedge, randomized trial to roll out patient navigation and patient and provider reminders across 15 clinics (3 clinics per step, 5 six-month steps).
Implementation strategies will include assessing for readiness, audit and feedback, building a community coalition, engaging consumers, modifying referral tracking, and training and educating clinical stakeholders.
The research team will use the electronic health record data with consideration for the Observational Medical Outcomes Partnership (OMOP) Common Data Model, additional patient-reported data, and study tracking logs to measure reach, effectiveness, adoption, implementation, and will use qualitative measures and site observations to document contextual factors, including examination of discrimination in patient experiences and provider referral patterns that may influence intervention delivery or colorectal cancer screening completion.
Study Overview
Status
Enrolling by invitation
Conditions
Intervention / Treatment
Detailed Description
Colorectal cancer (CRC) screening is recommended by the United States Preventative Services Task Force for adults age 45-75.
Patient navigation is an evidence-based strategy to increase screening rates among racial and ethnic minorities.
While patient navigation is an evidence-based approach to improve screening, there is a gap in understanding the multi-level influences on implementation of such programs across primary care practices, particularly using a health-equity focused, stakeholder-centered approach.
Guided by the Practical, Robust Implementation and Sustainability Model (PRISM) and core health and racial equity principles, the investigative team aims to increase reach of patient navigation and show effectiveness through improvement in the percentage of Black and Hispanic patients completing CRC screening.
Investigators will also utilize longitudinal tracking of implementation strategies to better track implementation or intervention adaptations navigation delivery in order to inform future scale up.
The research team will conduct a stepped-wedged, randomized trial to roll out patient navigation and patient and provider reminders across 15 clinics (3 clinics per step, 5 six-month steps).
Implementation strategies will include assessing for readiness, audit and feedback, building a community coalition, engaging consumers, modifying referral tracking, and training and educating clinical stakeholders.
Researchers will use the electronic health record data with consideration for the Observational Medical Outcomes Partnership (OMOP) Common Data Model, additional patient-reported data, and study tracking logs to measure reach, effectiveness, adoption, implementation, and will use qualitative measures and site observations to document contextual factors, including examination of discrimination in patient experiences and provider referral patterns that may influence intervention delivery or CRC screening completion.
Study Type
Interventional
Enrollment (Estimated)
1800
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
District of Columbia
-
Washington D.C., District of Columbia, United States, 20007
- Internal Medicine Wisconsin Avenue
-
Washington D.C., District of Columbia, United States, 20016
- Family Medicine Spring Valley
-
Washington D.C., District of Columbia, United States, 20036
- Primary Care Lafayette
-
Washington D.C., District of Columbia, United States, 20722
- Family Medicine Fort Lincoln
-
-
Maryland
-
Baltimore, Maryland, United States, 21128
- Honeygo
-
Baltimore, Maryland, United States, 21218
- MedStar Adult Medicine at Union Memorial
-
Baltimore, Maryland, United States, 21230
- Harbor Hospital Primary Care Federal Hill
-
Baltimore, Maryland, United States, 21237
- Franklin Square
-
Baltimore, Maryland, United States, 21237
- Primary Care at Franklin Square
-
Charlotte Hall, Maryland, United States, 20622
- Charlotte Hall
-
Clinton, Maryland, United States, 20735
- Internal Medicine Clinton
-
Gaithersburg, Maryland, United States, 20878
- Family Medicine
-
Hyattsville, Maryland, United States, 20782
- Internal Medicine Hyattsville
-
Olney, Maryland, United States, 20832
- Family Medicine
-
Olney, Maryland, United States, 20832
- Olney Prof Park
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Age 45-75
- Due for colorectal cancer screening
- Identify as Black or Hispanic/Latino
- Attend primary care visit at one of the 15 selected clinics within the step time -period
Exclusion Criteria:
-
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Screening
- Allocation: Randomized
- Interventional Model: Sequential Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Usual care
|
|
|
Experimental: Patient navigation
Patient navigation will be rolled out at the clinic level (15 clinics).
Referral orders will become available to participating clinics, with education and audit and feedback for providers.
The study team will tailor patient navigation supports by clinic site for specifics on how the intervention is delivered.
|
Clinics will receive educational materials and access a referral order for patient navigation.
Iterative strategies will be used to increase CRC screening
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Colorectal cancer screening completion
Time Frame: 12 months
|
Completion of any USPSTF approved screening test
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Reach
Time Frame: 6 months
|
Percent of patients referred out of those eligible
|
6 months
|
|
Adoption
Time Frame: 6 months
|
Percent of providers referring to patient navigation
|
6 months
|
|
Acceptability measured by the Acceptability of Intervention Measure (AIM)
Time Frame: 12 months
|
Stakeholder assessments of acceptability of navigation and implementation strategies measured on a four-item scale
|
12 months
|
|
Appropriateness measured by the Intervention Appropriateness Measure (IAM)
Time Frame: 12 months
|
Stakeholder assessments of appropriateness of navigation and implementation strategies measured on a four-item scale
|
12 months
|
|
Feasibility measured by the Feasibility of Implementation Measure (FIM)
Time Frame: 12 months
|
Stakeholder assessments of feasibility of navigation and implementation strategies measured on 4 item scale
|
12 months
|
|
Sustainability measured by the clinical sustainability assessment tool
Time Frame: 12 months
|
Understanding clinical sustainability of interventions
|
12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2024
Primary Completion (Estimated)
January 30, 2028
Study Completion (Estimated)
July 30, 2028
Study Registration Dates
First Submitted
April 22, 2024
First Submitted That Met QC Criteria
May 2, 2024
First Posted (Actual)
May 6, 2024
Study Record Updates
Last Update Posted (Estimated)
October 22, 2025
Last Update Submitted That Met QC Criteria
October 20, 2025
Last Verified
October 1, 2025
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 6963 (CTEP)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Colorectal Cancer Screening
-
University Hospital, CaenCentre Régional de Coordination du Dépistage des Cancers - Centre Val de... and other collaboratorsNot yet recruiting
-
Stanford UniversityHeidelberg Institute of Global Health, Heidelberg University, GermanyNot yet recruitingColorectal Cancer ScreeningUnited States
-
NYU Langone HealthNational Cancer Institute (NCI)Recruiting
-
Dartmouth-Hitchcock Medical CenterWhite River Junction Veterans Affairs Medical CenterNot yet recruitingColorectal Cancer Screening | Fecal Immunochemical TestUnited States
-
Nanfang Hospital, Southern Medical UniversityRecruitingBowel Preparation Solutions | Colonoscopy | Colorectal Cancer ScreeningChina
-
Morehouse School of MedicineRecruitingColorectal Cancer Screening | Bowel Cleansing for ColonoscopyUnited States
-
Fundacin Biomedica Galicia SurNot yet recruitingColonoscopy | Psychological Intervention | Colorectal Cancer Screening | Behavior Change | Psychological Factors | Colorectal Cancer Control and Prevention | Polyps Colorectal | Optical BiopsyNorway, Spain
-
Sunil PatelCompletedColonoscopy | Mass Screening | Colorectal Cancer ScreeningCanada
-
Memorial Sloan Kettering Cancer CenterRalph Lauren Center for Cancer Care and Prevention; North General Hospital,...Completed
-
Harvard School of Public Health (HSPH)National Cancer Institute (NCI); National Institutes of Health (NIH)CompletedBreast Cancer Screening | Implementation | Colorectal Cancer ScreeningUnited States
Clinical Trials on Delivery of patient navigation
-
University of Colorado, DenverDenver Health and Hospital Authority; Rocky Mountain Human Services; El Grupo...Completed
-
University of WashingtonNational Institute on Drug Abuse (NIDA)Active, not recruitingMedication Adherence | Methamphetamine-dependence | Opioid Use Disorder | Polysubstance Drug Use (Indiscriminate Drug Use)United States
-
University of UtahUniversity of PittsburghCompletedPregnancy Related | Pregnancy, High Risk | Opioid-Related DisordersUnited States
-
Massachusetts General HospitalAmerican Cancer Society, Inc.CompletedTobacco Use | Lung Cancer | HomelessnessUnited States
-
Instituto Nacional de Ciencias Medicas y Nutricion...Global Cancer InstituteCompleted
-
Massachusetts General HospitalCompleted
-
Emory UniversityCompletedEnd-Stage Renal DiseaseUnited States
-
The Netherlands Cancer InstituteUnknown
-
Massachusetts General HospitalCompletedColorectal CancerUnited States
-
Boston Medical CenterCompleted